Geode Capital Management, LLC Point Biopharma Global Inc. Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$6.67 - $9.71 $1.17 Million - $1.7 Million	174,687 Added 10.12%	1,900,074 $12.7 Million
Q2 2023 Aug 11, 2023	BUY	$6.86 - $10.86 $987,510 - $1.56 Million	143,952 Added 9.1%	1,725,387 $15.6 Million
Q1 2023 May 15, 2023	BUY	$6.78 - $8.1 $753,766 - $900,517	111,175 Added 7.56%	1,581,435 $11.5 Million
Q4 2022 Feb 13, 2023	BUY	$5.72 - $9.78 $1.19 Million - $2.03 Million	207,662 Added 16.45%	1,470,260 $10.7 Million
Q3 2022 Nov 14, 2022	SELL	$7.24 - $10.31 $477,441 - $679,892	-65,945 Reduced 4.96%	1,262,598 $9.76 Million
Q2 2022 Aug 12, 2022	BUY	$5.6 - $9.5 $3.52 Million - $5.97 Million	628,860 Added 89.88%	1,328,543 $9.05 Million
Q1 2022 May 13, 2022	BUY	$5.46 - $8.13 $430,291 - $640,709	78,808 Added 12.69%	699,683 $5.58 Million
Q4 2021 Feb 11, 2022	BUY	$4.83 - $9.75 $527,711 - $1.07 Million	109,257 Added 21.36%	620,875 $3.48 Million
Q3 2021 Nov 12, 2021	BUY	$7.42 - $11.26 $3.8 Million - $5.76 Million	511,618 New	511,618 $3.93 Million

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.